BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12028034)

  • 1. Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease.
    Porrata LF; Inwards DJ; Micallef IN; Ansell SM; Geyer SM; Markovic SN
    Br J Haematol; 2002 Jun; 117(3):629-33. PubMed ID: 12028034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
    Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma.
    Gordan LN; Sugrue MW; Lynch JW; Williams KD; Khan SA; Moreb JS
    Bone Marrow Transplant; 2003 Jun; 31(11):1009-13. PubMed ID: 12774052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of absolute lymphocyte count recovery kinetics on survival after autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Yoong Y; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Litzow MR; Gertz MA; Lacy MQ; Dispenzieri A; Gastineau DA; Tefferi A; Elliott M; Snow DS; Hogan WJ; Markovic SN
    Leuk Lymphoma; 2005 Sep; 46(9):1287-94. PubMed ID: 16109605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
    Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN
    Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.
    Porrata LF; Gertz MA; Inwards DJ; Litzow MR; Lacy MQ; Tefferi A; Gastineau DA; Dispenzieri A; Ansell SM; Micallef IN; Geyer SM; Markovic SN
    Blood; 2001 Aug; 98(3):579-85. PubMed ID: 11468153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma.
    Kim Y; Kim SJ; Cheong JW; Cho H; Chung H; Lee JY; Jang JE; Min YH; Kim JS
    Hematol Oncol; 2017 Dec; 35(4):465-471. PubMed ID: 27440113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute lymphocyte count recovery after allogeneic hematopoietic stem cell transplantation predicts clinical outcome.
    Kim HT; Armand P; Frederick D; Andler E; Cutler C; Koreth J; Alyea EP; Antin JH; Soiffer RJ; Ritz J; Ho VT
    Biol Blood Marrow Transplant; 2015 May; 21(5):873-80. PubMed ID: 25623931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma.
    Porrata LF; Litzow MR; Inwards DJ; Gastineau DA; Moore SB; Pineda AA; Bundy KL; Padley DJ; Persky D; Ansell SM; Micallef IN; Markovic SN
    Bone Marrow Transplant; 2004 Feb; 33(3):291-8. PubMed ID: 14676784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
    Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
    Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders.
    Boulassel MR; Herr AL; deB Edwardes MD; Galal A; Lachance S; Laneuville P; Routy JP
    Hematology; 2006 Jun; 11(3):165-70. PubMed ID: 17325956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study.
    Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Litzow MR; Winters JL; Markovic SN
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):807-16. PubMed ID: 18541201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.
    Joao C; Porrata LF; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Gastineau DA; Markovic SN
    Bone Marrow Transplant; 2006 May; 37(9):865-71. PubMed ID: 16532015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
    Majolino I; Pearce R; Taghipour G; Goldstone AH
    J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma.
    Kewalramani T; Nimer SD; Zelenetz AD; Malhotra S; Qin J; Yahalom J; Moskowitz CH
    Bone Marrow Transplant; 2003 Oct; 32(7):673-9. PubMed ID: 13130314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant.
    Seshadri T; Pintilie M; Keating A; Crump M; Kuruvilla J
    Bone Marrow Transplant; 2008 Jul; 42(1):29-34. PubMed ID: 18332908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant.
    Jimenez-Zepeda VH; Reece DE; Trudel S; Chen C; Franke N; Winter A; Tiedemann R; Kukreti V
    Leuk Lymphoma; 2015; 56(9):2668-73. PubMed ID: 25573201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis.
    Porrata LF; Gertz MA; Litzow MR; Lacy MQ; Dispenzieri A; Inwards DJ; Ansell SM; Micallef IN; Gastineau DA; Elliott M; Hogan WJ; Hayman SR; Tefferi A; Markovic SN
    Clin Cancer Res; 2005 Feb; 11(3):1210-8. PubMed ID: 15709191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte recovery as a positive predictor of prolonged survival after autologous peripheral blood stem cell transplantation in T-cell non-Hodgkin's lymphoma.
    Kim H; Sohn HJ; Kim SE; Kang HJ; Park S; Kim S; Kim WK; Lee JS; Suh C
    Bone Marrow Transplant; 2004 Jul; 34(1):43-9. PubMed ID: 15107814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Porrata LF; Litzow MR; Tefferi A; Letendre L; Kumar S; Geyer SM; Markovic SN
    Leukemia; 2002 Jul; 16(7):1311-8. PubMed ID: 12094255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.